\n\u2022 Provides live microorganisms that form part of a natural healthy gut flora
\n\u2022 Probiotics to significantly reduce symptoms of irritable bowel syndrome (IBS)
\n\u2022 Probiotics to supplement the normal intestinal microbiota following antibiotic therapy
\n\u2022 Provides 75 billion CFU per day from human-sourced probiotics:\u00a0Lactobacillus acidophilus<\/em>\u00a0(CUL-60 and CUL-21),\u00a0Bifidobacterium bifidum<\/em>\u00a0(CUL-20),\u00a0Bifidobacterium animalis<\/em>\u00a0subsp.\u00a0lactis<\/em>\u00a0(CUL-34),\u00a0Lactobacillus salivarius<\/em>\u00a0(CUL-61)
\n\u2022 Contains fructooligosaccharides (FOS)<\/p>\n
HMF Replete supports healthy intestinal microflora throughout antibiotic use and in adults with IBS. The intestines contain more than 400 bacterial species, and bacterial balance needs to be maintained for healthy intestines.1<\/sup>\u00a0Antibiotics alter intestinal microflora, and can result in the proliferation of antibiotic resistant bacteria.2<\/sup>\u00a0Probiotics promote naturally healthy microflora and support normal intestinal microbiota following antibiotic therapy.2<\/sup>IBS affects nearly 5 million Canadians and can also result from altered intestinal microflora.2,3<\/sup>\u00a0This leads to malabsorption of bile acids \u2013 which aid in fat digestion \u2013 and in turn, increases fluid and mucus secretion into the colon for bile acid dilution.2<\/sup>\u00a0As Lactobacilli and Bifidobacteria help reabsorb bile acids, less water enters the colon, decreasing diarrheal occurrence.2<\/sup>\u00a0In a randomized, placebo-controlled trial involving 52 adults with IBS, daily supplementation with CUL-60, CUL-21, CUL-20 and CUL-34 significantly improved quality of life and bowel habit satisfaction scores, and decreased the number of days with pain within 10 weeks.4<\/sup><\/p>\n <\/p>\n REFERENCES <\/p>\n","protected":false},"excerpt":{"rendered":" 58.32 Promotes healthy gut flora in adults during antibiotic intake and in adults with IBS \u2022 Provides live microorganisms that form part of a natural healthy gut flora \u2022 Probiotics to significantly reduce symptoms of irritable bowel syndrome (IBS) \u2022 Probiotics to supplement the normal intestinal microbiota following antibiotic therapy \u2022 Provides 75 billion CFU per day from human-sourced probiotics:\u00a0Lactobacillus acidophilus\u00a0(CUL-60 and CUL-21),\u00a0Bifidobacterium bifidum\u00a0(CUL-20),\u00a0Bifidobacterium animalis\u00a0subsp.\u00a0lactis\u00a0(CUL-34),\u00a0Lactobacillus salivarius\u00a0(CUL-61) \u2022 Contains fructooligosaccharides (FOS) HMF Replete supports healthy intestinal microflora throughout antibiotic use and in adults with IBS. The intestines contain more than 400 bacterial species, and bacterial balance needs to be maintained for healthy intestines.1\u00a0Antibiotics alter intestinal microflora, and can result in the proliferation of antibiotic resistant bacteria.2\u00a0Probiotics promote naturally healthy microflora and support normal intestinal microbiota following antibiotic therapy.2IBS affects nearly 5 million Canadians and can also result from altered intestinal microflora.2,3\u00a0This leads to malabsorption of bile acids \u2013 which aid in fat digestion \u2013 and in turn, increases fluid and mucus secretion into the colon for bile acid dilution.2\u00a0As Lactobacilli and Bifidobacteria help reabsorb bile acids, less water enters the colon, decreasing diarrheal occurrence.2\u00a0In a randomized, placebo-controlled trial involving 52 adults with IBS, daily supplementation with CUL-60, CUL-21, CUL-20 and CUL-34 […]<\/p>\n","protected":false},"featured_media":4514,"template":"","meta":{"wds_primary_product_brand":0,"wds_primary_product_cat":0},"product_brand":[],"product_cat":[84],"product_tag":[],"class_list":{"0":"post-4504","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-probiotics","8":"first","9":"instock","10":"taxable","11":"shipping-taxable","12":"purchasable","13":"product-type-simple"},"yoast_head":"\n
\n1. \u0007Nagpal, R, Yadav, H, Kumar, M, Jain, S, Yamashiro, Y, Marotta, F. (2013). In Otles, S. (Ed.), Probiotics and Prebiotics in Food, Nutrition and Health (pp. 1-24). Boca Raton, FL: CRC Press.
\n2. \u0007Sarowska, J, Choroszy-Kr\u2014l, I, Regulska-Ilow, B, Frej-Madrzak, M, Jama-Kmiecik, A. Adv Clin Exp Med. 2013; 22(5): 759-766.
\n3. \u0007Fedorak, RN, Vanner, SJ, Paterson, WG, Bridges, RJ. Can J Gastroenterol. 2012; 26(5): 252-256.
\n4. \u0007Williams, EA, Stimpson, J, Wang, D, Plummer, S, Garaiova, I, Barker, ME, Corfe, BM. Aliment Pharmacol Ther. 2008; 29: 97-10![\"\"](\"https:\/\/www.satorihealth.ca\/blog\/wp-content\/uploads\/2018\/05\/419_HMF_Replete_CA.png\")
<\/p>\n